On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJan 31, 2017 9:44 am

Social Reality, Inc. (NASDAQ: SRAX) Releases Preliminary FY2016 Results

Internet advertising and platform technology company Social Reality, Inc. (NASDAQ: SRAX) yesterday released certain preliminary unaudited operating results for both the fourth quarter and full year of 2016. Among the highlights, the company reported unaudited gross revenue of $11.5 million for the fourth quarter, which represents a 41 percent year-over-year increase and a 20 percent rise from the third quarter of 2016. Similarly, unaudited gross profits for the three-month period totaled $4.7 million, up 86 percent from the prior quarter. Social Reality attributed this strong performance to an increase in SRAX sell-side clients, as well as the continuing growth of…

Continue Reading

TuesdayJan 31, 2017 9:30 am

Safeguard Scientifics, Inc. (NYSE: SFE) Starts Presentation at NobleCon13

Safeguard Scientifics (NYSE: SFE) provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. The company targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the internet of everything, enhanced security and predictive analytics. Safeguard Scientifics typically deploys between $5 million and $25 million over the course of its partnership with a company, initially investing in a Series A or B Round and opportunistically in a Seed Round. It has a distinguished track record of fostering innovation and building market leaders that spans…

Continue Reading

TuesdayJan 31, 2017 9:30 am

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at NobleCon13

Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage pharmaceutical company that develops medicines for common disorders of the central nervous system. The company’s lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, a phase III clinical stage for the treatment of PTSD; and phase II clinical stage for the treatment of military-related PTSD. For more information, visit the company’s website www.tonixpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

TuesdayJan 31, 2017 9:30 am

Naked Brand Group, Inc. (NASDAQ: NAKD) Starts Presentation at NobleCon13

Naked Brand (NASDAQ: NAKD) designs, manufactures and sells men’s and women’s underwear, intimate apparel, loungewear and sleepwear products in the United States and Canada. It offers various innerwear products for men, including boxer briefs, trunks, briefs, undershirts, T-shirts, lounge pants, lounge shorts and robes, as well as loungewear and sleepwear products for women, such as boyshorts, hipsters, lounge pants and tops, camisoles, tank tops, pajamas, chemises, sleepshirts and robes primarily under the Naked brand name. The company sells its products to consumers and retailers through wholesale channels and direct-to-consumer channels. For more information, visit the company’s website at www.thenakedshop.com. About NetworkNewsWire…

Continue Reading

MondayJan 30, 2017 4:00 pm

Finjan Holdings, Inc. (NASDAQ: FNJN) Starts Presentation at NobleCon13

Finjan Holdings (NASDAQ: FNJN) operates as a cybersecurity company and provider of intellectual property licensing and enforcement services. The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end-users from identity and data theft, spyware, malware, phishing, Trojans, and other web and network threats. Finjan’s patented technologies are used in specific technology areas, including endpoint/cloud software, web gateway/Internet infrastructure, and networking equipment markets. The company’s technology scans and repels the latest and unknown threats to network, web, and endpoint devices on a real-time basis.  For more information, visit the…

Continue Reading

MondayJan 30, 2017 4:00 pm

Creative Realities, Inc. (CREX) Starts Presentation at NobleCon13

Creative Realities (OTC: CREX) provides digital marketing technology solutions to retailers, brand marketers, venue-operators, enterprises, non-profits and other organizations in the United States and internationally. Its technology and solutions include digital merchandising systems, interactive digital shopping assistants and kiosks, mobile digital marketing platforms, digital way-finding platforms, digital menu board systems, dynamic signage, and other digital marketing technologies. The company enables its client to engage with consumers via technology and solutions that interact with mobile, social media, point-of-sale, wireless networks, and web-based platforms. The company sells its solutions to the hospitality, branded retail, automotive, food service, and retail healthcare industries. For…

Continue Reading

MondayJan 30, 2017 4:00 pm

CV Sciences, Inc. (CVSI) Starts Presentation at NobleCon13

CV Sciences (OTC: CVSI) focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments, Specialty Pharmaceutical and Consumer Product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods and vape. The company’s Pharmaceutical Division is developing synthetically formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of…

Continue Reading

MondayJan 30, 2017 3:30 pm

Hyperdynamics Corp. (HDYN) Starts Presentation at NobleCon13

Hyperdynamics (OTC: HDYN) is an independent oil and gas exploration company engaged in the acquisition, exploration and development of oil and natural gas properties in the Republic of Guinea, Northwest Africa. The company owns a 100% interest in a concession that covers an area of approximately 7,238 square miles in offshore Guinea. Hyperdynamics was founded in 1983 and is headquartered in Houston, Texas. For more information, visit the company’s website at www.hyperdynamics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

Continue Reading

MondayJan 30, 2017 3:30 pm

MassRoots, Inc. (MSRT) Starts Presentation at NobleCon13

MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company’s mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars and stickers, as well as MassRoots for Business, a free online portal for dispensaries to schedule posts, view analytics and gain insights into followers. For more information, visit the company’s website at www.massroots.com. About…

Continue Reading

MondayJan 30, 2017 3:30 pm

Microbot Medical, Inc. (NASDAQ: MBOT) Starts Presentation at NobleCon13

Microbot Medical (NASDAQ: MBOT) is a medical device company, engaging in the research, design, development and commercialization of micro-robotics medical technologies. The company’s ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self-Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel. For more information, visit the company’s website at www.microbotmedical.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

Continue Reading

Contact us: 212.418.1217